Citigroup’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Citigroup’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-14,293	Closed	-$514K	–	7848
2020 Q4	$514K	Buy	14,293 +12,981	+989%	+$455K	﹤0.01%	4185
2020 Q3	$36K	Sell	1,312 -6,060	-82%	-$214K	﹤0.01%	5809
2020 Q2	$319K	Buy	7,372 +5,711	+344%	+$259K	﹤0.01%	4645
2020 Q1	$63K	Buy	1,661 +565	+52%	+$22K	﹤0.01%	5763
2019 Q4	$30K	Buy	+1,096	New	+$27.6K	﹤0.01%	6728

Citigroup's VIE Position: Q1 2021 in Review

Citigroup sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 14,293 shares — an estimated $514K sold.

Citigroup first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $514K in Q4 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Citigroup reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Citigroup sold 14,293 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $514K.
Citigroup first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Citigroup's Viela Bio, Inc. Common Stock position peaked at $514K in Q4 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Citigroup's 13F filing for Q1 2021, filed 13 May 2021.